Literature DB >> 16740692

Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.

Jeffrey A Toretsky1, Verda Erkizan, Amy Levenson, Ogan D Abaan, Jeffrey D Parvin, Timothy P Cripe, Anna M Rice, Sean Bong Lee, Aykut Uren.   

Abstract

RNA helicase A (RHA), a member of the DEXH box helicase family of proteins, is an integral component of protein complexes that regulate transcription and splicing. The EWS-FLI1 oncoprotein is expressed as a result of the chromosomal translocation t(11;22) that occurs in patients with the Ewing's sarcoma family of tumors (ESFT). Using phage display library screening, we identified an EWS-FLI1 binding peptide containing homology to RHA. ESFT cell lines and patient tumors highly expressed RHA. GST pull-down and ELISA assays showed that EWS-FLI1 specifically bound RHA fragment amino acids 630 to 1020, which contains the peptide region discovered by phage display. Endogenous RHA was identified in a protein complex with EWS-FLI1 in ESFT cell lines. Chromatin immunoprecipitation experiments showed both EWS-FLI1 and RHA bound to EWS-FLI1 target gene promoters. RHA stimulated the transcriptional activity of EWS-FLI1 regulated promoters, including Id2, in ESFT cells. In addition, RHA expression in mouse embryonic fibroblast cells stably transfected with EWS-FLI1 enhanced the anchorage-independent phenotype above that with EWS-FLI1 alone. These results suggest that RHA interacts with EWS-FLI1 as a transcriptional cofactor to enhance its function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740692     DOI: 10.1158/0008-5472.CAN-05-3293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

Review 1.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Authors:  Stephen L Lessnick; Marc Ladanyi
Journal:  Annu Rev Pathol       Date:  2011-09-19       Impact factor: 23.472

Review 2.  Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Authors:  Hayriye V Erkizan; Vladimir N Uversky; Jeffrey A Toretsky
Journal:  Clin Cancer Res       Date:  2010-06-14       Impact factor: 12.531

Review 3.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  In vitro and in vivo analysis of the interaction between RNA helicase A and HIV-1 RNA.

Authors:  Li Xing; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.

Authors:  Hyewon Park; Timothy K Turkalo; Kayla Nelson; Stephen Sai Folmsbee; Caroline Robb; Brittany Roper; Mizuki Azuma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.

Authors:  Hayriye Verda Erkizan; Jeffrey A Schneider; Kamal Sajwan; Garrett T Graham; Brittany Griffin; Sergey Chasovskikh; Sarah E Youbi; Abraham Kallarakal; Maksymilian Chruszcz; Radhakrishnan Padmanabhan; John L Casey; Aykut Üren; Jeffrey A Toretsky
Journal:  Nucleic Acids Res       Date:  2015-01-06       Impact factor: 16.971

7.  New strategies in ewing sarcoma: lost in translation?

Authors:  Fernanda I Arnaldez; Lee J Helman
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

8.  Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.

Authors:  Atul Kondaskar; Shilpi Kondaskar; Raj Kumar; James C Fishbein; Nidal Muvarak; Rena G Lapidus; Mariola Sadowska; Martin J Edelman; Guus M Bol; Farhad Vesuna; Venu Raman; Ramachandra S Hosmane
Journal:  ACS Med Chem Lett       Date:  2010-12-31       Impact factor: 4.345

9.  Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.

Authors:  Patrick P Lin; Yongxing Wang; Guillermina Lozano
Journal:  Sarcoma       Date:  2010-10-05

10.  High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.

Authors:  Ola Awad; Jason T Yustein; Preeti Shah; Naheed Gul; Varalakshmi Katuri; Alison O'Neill; Yali Kong; Milton L Brown; Jeffrey A Toretsky; David M Loeb
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.